Fawzi Abu Rous: Integrating the Latest Evidence Into the Treatment of EGFR-mutated NSCLC
Fawzi Abu Rous/LinkedIn

Fawzi Abu Rous: Integrating the Latest Evidence Into the Treatment of EGFR-mutated NSCLC

Fawzi Abu Rous, Medical Oncologist at Henry Ford Health, shared Journal of Clinical Oncology’s post on LinkedIn:

“Happening now at TTLC26: Live Tumor Board – From Trial to Practice: Integrating the Latest Evidence Into the Treatment of EGFR-mutated NSCLC

Come join me, Julia Rotow, and Jonathan Riess at this great PER event!”

Fawzi Abu Rous

Other articles featuring Fawzi Abu Rous on OncoDaily.